Nov 11, 2022 / 06:40PM GMT
Marc Frahm - Cowen - MD, Healthcare
Hi, welcome to the next session of the sixth annual Cowen IO Next Summit. We are really pleased to have with us today for the next session, Marty Huber, President and Head of R&D from Xilio Therapeutics. And I would remind all the investors on the line that while I do have a question list that I can run through with Marty, we'd love to have this be as interactive as possible. So you can submit questions either through the chat function of the webcast or you can email me directly at [email protected].
Questions and Answers:
Marc Frahm - Cowen - MD, HealthcareSo maybe just to start off, Marty, just to level set people who may not be in depth truly familiar with Xilio, just can you give a brief overview of the GPS platform, NK, how it works, and why it's ideally suited for delivering cytokines or other biologics?
Marty Huber - Xilio Therapeutics, Inc. - President & Head of R&D
Thank you. And first of all, I'll say hello from Boston at [Fitzy]. We're actually at
Trustpilot
